Zobrazeno 1 - 10
of 210
pro vyhledávání: '"Chronic hepatitis C infection"'
Autor:
Laura Huiban, Carol Stanciu, Cristina Maria Muzica, Irina Girleanu, Raluca Avram, Ioana Damian, Robert Nastasa, Ermina Stratina, Sebastian Zenovia, Horia Minea, Remus Stafie, Adrian Rotaru, Ana-Maria Singeap, Stefan Chiriac, Ioana-Miruna Balmus, Anca Trifan
Publikováno v:
Medicina, Vol 60, Iss 9, p 1539 (2024)
Background and Objectives: Sustained virologic responses (SVRs) lead to a decrease in portal hypertension, the regression of fibrosis, and the improvement in the hepatic synthesis of procoagulant and anticoagulant factors. We aimed to assess the infl
Externí odkaz:
https://doaj.org/article/da1fea76fc2f459b98e16b01eedc493e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Medicina, Vol 59, Iss 3, p 602 (2023)
Background and Objectives: Direct-acting antivirals (DAAs) are highly effective for the treatment of chronic hepatitis C virus (HCV) infection, but the risk of liver-related events and hepatocellular carcinoma (HCC) remains after successful therapy.
Externí odkaz:
https://doaj.org/article/657e4812e8214643a741f3d78fd57ed3
Autor:
Fathy Ghamry Abdelrazik, Mohammed Salah Ali Hussein, Zakarya Mohammed Zakarya Shady, Mohammed Assem Khorshid, Abdelhalim A Elsherif, Tarek Abd El-Kareem Al Dahshan
Publikováno v:
Al-Azhar Assiut Medical Journal, Vol 19, Iss 1, Pp 46-51 (2021)
Background There are laboratory and clinical associations between liver and thyroid diseases. Hepatitis C virus is known to be responsible for both hepatic and extrahepatic diseases. Direct-acting antivirals (DAAs) provide high sustained viral respon
Externí odkaz:
https://doaj.org/article/88b8f16456374eec84e97e43a5a008fa
Publikováno v:
Журнал инфектологии, Vol 12, Iss 5, Pp 85-92 (2021)
Study Objective: to assess the impact of herpesviruses infections reactivation and concomitant chronic hepatitis C infection (CHC) on complications and one-year survival after hemopoietic stem cell transplantation (HSCT) in patients with hematologic
Externí odkaz:
https://doaj.org/article/e81279f7e6944c7eba4edd60930e5fdf
Publikováno v:
Журнал инфектологии, Vol 12, Iss 1, Pp 91-95 (2020)
Objective: clinical and laboratory characteristics of HCV infection in patients with oncohematological malignancies. Materials and Methods: The study included 106 patients with a positive serum HCV antibody (anti-HCV) test result, who were examined o
Externí odkaz:
https://doaj.org/article/cd71265990084087a4cc1577f619d8f0
Autor:
Anca Trifan, Tudor Cuciureanu, Robert Nastasa, Ermina Stratina, Sebastian Zenovia, Cristina Maria Muzica, Laura Huiban, Ana-Maria Singeap, Stefan Chiriac, Catalin Sfarti, Camelia Cojocariu, Irina Girleanu, Horia Minea, Remus Stafie, Adrian Rotaru, Carol Stanciu
Publikováno v:
Life, Vol 13, Iss 2, p 534 (2023)
Chronic hepatitis C infection is a systemic disease that affects over 71 million patients all over the world and it is to be considered nowadays as a new cardiometabolic risk factor. This study aimed to evaluate the weight and metabolic changes after
Externí odkaz:
https://doaj.org/article/429454303e7a4dc6a4a2450745970ae0
Autor:
Jesús Quintero, Javier Juampérez, Ecaterina Julio, Vanessa Cabello, Maria Mercadal-Hally, Pere Soler-Palacín, Óscar Segarra, Carlos Rodrigo
Publikováno v:
Anales de Pediatría, Vol 90, Iss 3, Pp 141-147 (2019)
Resumen: Introducción: El objetivo del estudio fue evaluar la seguridad y la eficacia de la combinación de ledipasvir/sofosbuvir en la infección crónica por el genotipo 1 y 4 del virus de la hepatitis C (VHC) en pacientes pediátricos. Métodos:
Externí odkaz:
https://doaj.org/article/63739a4c6a7a4930b5b4a23c3e7eb346
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background: Liver fibrosis stage determines the risk of morbidity and mortality from chronic hepatitis C virus (HCV) infection. The majority of HCV-infected patients are underserved and have other comorbid conditions that lead to more progressive liv
Externí odkaz:
https://doaj.org/article/90da4097ab714efca2e711bd2c5ff3c5
Publikováno v:
EBioMedicine, Vol 21, Iss C, Pp 182-187 (2017)
Background: The most recent European Association for the Study of the Liver (EASL) 2016 Guidelines on treatment of hepatitis C (HCV), allowed for shortening the course of treatment for some subsets of patients with sofosbuvir/ledipasvir and with graz
Externí odkaz:
https://doaj.org/article/ec20918b0fff4017aefd23386812e6f9